FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...
Insects thrive in incredibly diverse and challenging environments. While we now know that nutrient-sensing pathways, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback